Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05751863 · ClinicalTrials.gov registry record · NA

Analgesia-First Sedation in Trauma Patients

A NA study of Respiratory Failure and Mechanical Ventilation, sponsored by MemorialCare Health System.

Recruiting
Registry status
NA
Development phase
170
Enrollment target
1
Study location

NCT05751863: Recruiting NA study of Respiratory Failure and Mechanical Ventilation, sponsored by MemorialCare Health System.

NCT05751863 is a NA study of Respiratory Failure and Mechanical Ventilation that is actively recruiting participants, run by MemorialCare Health System. The registered enrollment target is 170 participants, below the 4,520-participant average among 40 other Respiratory Failure trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05751863, a NA study of Respiratory Failure and Mechanical Ventilation, is actively recruiting participants, sponsored by MemorialCare Health System.

RECRUITING
Registry status
NA
Development phase
170 participants
Enrollment target
1
Study location

Study Summary

The study's aim is to ascertain the best approach for providing sedation and pain management for patients who have sustained trauma and are requiring respiratory support from a mechanical ventilator. The common approach to patients who need mechanical ventilation is to provide continuous drips of sedatives and pain medicine and awaken the patient once a day to check the brain functions. Another approach is to provide pain medicine and reserve sedatives for only a short duration when needed. The difference between approaches has not been studied in Trauma patients.

Primary Outcome

Duration of mechanical ventilation

Interventions

  • OTHER Analgesia First Sedation Strategy for Mechanically Ventilated (MV) Trauma Subjects
  • OTHER Protocol Directed Sedation and Daily Sedation Interruption

Study Locations (1)

California

  • Long Beach Memorial Medical Center - Long Beach

Trial Details

FieldValue
Enrollment Target 170 participants
Start Date 2023-04-01
Est. Completion 2026-09-01
Phase NA
MemorialCare Health System

21 total trials

What NCT05751863 shows while recruiting

NCT05751863 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 4,520-participant average among 40 other Respiratory Failure trials with a reported enrollment target (96% lower).

The record links to 2 conditions, with Respiratory Failure appearing as the primary indexed condition, and to 2 interventions - of which Analgesia First Sedation Strategy for Mechanically Ventilated (MV) Trauma Subjects is the first listed.

NCT05751863 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05751863 about?

NCT05751863 is a clinical study titled "Analgesia-First Sedation in Trauma Patients". The study's aim is to ascertain the best approach for providing sedation and pain management for patients who have sustained trauma and are requiring respiratory support from a mechanical ventilator. The common approach to patients who need mechanical ventilation is to provide continuous drips of se...

What is the current status of trial NCT05751863?

This trial is currently recruiting. It is a NA study. The enrollment target is 170 participants. The study started on 2023-04-01. Estimated completion is 2026-09-01.

What conditions does trial NCT05751863 study?

This clinical trial studies the following conditions: Respiratory Failure, Mechanical Ventilation.

What interventions are being tested in trial NCT05751863?

The interventions under investigation include: Analgesia First Sedation Strategy for Mechanically Ventilated (MV) Trauma Subjects (OTHER), Protocol Directed Sedation and Daily Sedation Interruption (OTHER).

Who is sponsoring clinical trial NCT05751863?

This trial is sponsored by MemorialCare Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05751863 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Respiratory Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05751863's enrollment target sits among peer trials

170 17th of 40 higher than 24 of 40 other Respiratory Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Respiratory Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02016430 · 170 participants · NA

    Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)

  • NCT02621021 · 170 participants · Phase 2

    A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab

  • NCT04094701 · 170 participants · NA

    Hip Arthroscopy Postoperative Opioid Demands

  • NCT04166409 · 170 participants · Phase 3

    A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05751863, the US trial registry maintained by the National Library of Medicine. NCT05751863 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.